Intellikine's Grant - III Round

Intellikine raised a round of funding on March 05, 2010. Investors include Multiple Myeloma Research Foundation.

Intellikine is developing small molecule therapies targeting the PI3K/mTOR pathway for treatment of cancer, inflammation and autoimmune diseases. In December 2011, Intellikine was acquired by Taked…

Articles about Intellikine's Grant - III Round: